Clinical Trial Update: Clinical Trial With MSC for Graft Versus Host Disease Treatment [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluating mesenchymal stem cells for the treatment of acute graft-versus-host disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• MSC (mesenchymal stem cells) (mesenchymal stem cells)

Snippet

Sponsor: Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud | Conditions: Acute Graft Versus Host Disease | Phase 1, Phase 2 | Status: COMPLETED